Cargando…
Iron and hepcidin as risk factors in atherosclerosis: what do the genes say?
BACKGROUND: Previous reports suggested a role for iron and hepcidin in atherosclerosis. Here, we evaluated the causality of these associations from a genetic perspective via (i) a Mendelian randomization (MR) approach, (ii) study of association of atherosclerosis-related single nucleotide polymorphi...
Autores principales: | Galesloot, Tessel E., Janss, Luc L., Burgess, Stephen, Kiemeney, Lambertus A. L. M., den Heijer, Martin, de Graaf, Jacqueline, Holewijn, Suzanne, Benyamin, Beben, Whitfield, John B., Swinkels, Dorine W., Vermeulen, Sita H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498499/ https://www.ncbi.nlm.nih.gov/pubmed/26159428 http://dx.doi.org/10.1186/s12863-015-0246-4 |
Ejemplares similares
-
Cohort Profile: The Nijmegen Biomedical Study (NBS)
por: Galesloot, Tessel E, et al.
Publicado: (2017) -
A Comparison of Multivariate Genome-Wide Association Methods
por: Galesloot, Tessel E., et al.
Publicado: (2014) -
Meta-GWAS and Meta-Analysis of Exome Array Studies Do Not Reveal Genetic Determinants of Serum Hepcidin
por: Galesloot, Tessel E., et al.
Publicado: (2016) -
Known susceptibility SNPs for sporadic prostate cancer show a similar association with “hereditary” prostate cancer
por: Cremers, Ruben G., et al.
Publicado: (2015) -
Transferrin Saturation/Hepcidin Ratio Discriminates TMPRSS6-Related Iron Refractory Iron Deficiency Anemia from Patients with Multi-Causal Iron Deficiency Anemia
por: van der Staaij, Hilde, et al.
Publicado: (2022)